# Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.

> **NCT00474864** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 66 (actual)

## Conditions studied

- Healthy Subjects
- Dyslipidaemias
- Dyslipidaemia

## Interventions

- **DRUG:** GW856553

## Key facts

- **NCT ID:** NCT00474864
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2012-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00474864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00474864, "Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00474864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*